Co-organizers Technology Portfolio

Co-organizers Technology Portfolio Login

McGill University and the Research Institute of the McGill University Health Centre Technology Portfolio
ID #	Title	PDF	Video	Information Request
McGill 99033	Adaptable Nanosphere Drug Delivery System
McGill 10084	SHOWCASE:INFECTIOUS DISEASES: Vaccine Adjuvant Platform
McGill 10051	SHOWCASE:CNS: Agonistic TrkB Antibody for Glaucoma Treatment
McGill 10048	Polyphenol Compounds for Inhibiting Proteasome
McGill 10001	Hybrid Compounds with Retinoid Agonism and HDAC Inhibition for Cancer Therapy
McGill 09123	Electrochemically Controlled Microcantilever Biosensor
McGill 09120	Soluble IGF-1 Receptor for Treatment of Cancer and Metastasis
McGill 09086	SHOWCASE:CANCER: Chemosensitizing Agents for Multidrug Resistance (MDR) & Chemotherapy
McGill 09065	SHOWCASE:IMMUNE DISORDERS: A Chemistry Platform for Gene Silencing: Antisense and siRNA
McGill 09048	Single Chain Antibodies for in vivo pancreatic β cell imaging
McGill 09044	SHOWCASE:RESPIRATORY:First in Class 5-OXO-ETE Receptor Antagonists
McGill 09020	Light-Directed, in situ Synthesis of RNA Microarrays
McGill 08079	A Biological CCR2 Antagonist with Immunosuppressive and Anticancer Properties
McGill 08057	Natural, Non-Toxic, Fluorescent Emitting Nanoparticle for Drug Delivery
McGill 08049	Novel Treatment for ALS and Acute SCI
McGill 08047	Novel Treatment of Viral Infections
McGill 08034	Fitted 2.2: A Docking Software Program that Docks Small Molecules into Flexible and Partially Solvated Proteins
McGill 08019	DNA Nanocapsules for Controlled Drug Delivery
McGill 08004	Innovative Wrist Arthroplasty System
McGill 07116	Rapid Malaria Detection
McGill 07084	Microfluidic Microarrays for Multiplex Protein Analysis
McGill 07060	A Highly Expandable Cage for Vertebral Body Replacement
McGill 07037	Universal Electronic Microfluidic Systems
McGill 07033	A Breast Cancer Prognostic Test for Enhanced Clinical Outcome
McGill 06087S	SHOWCASE:CANCER:Fusion Protein Platform: Anti-Cancer, Anti-Inflammatory and Immunosuppressive Properties
McGill 06087	GIFT15, a Biological Immunosuppressant for Systemic Administration or ex-vivo Use
McGill 06083	Chemosensitizing Agents for Multidrug Resistance (MDR) & Chemotherapy
McGill 06080	Hydrogel Biosensors for Quantifying Analytes by Ultrasound
McGill 06069	Anticancer Vitamin D Agonists with HDAC Inhibitory Activity
McGill 06052	A New Chemistry Platform for RNA Interference
McGill 06031	Inflammation and Lipid Imbalance in CF
McGill 06019	Melatonin Ligands for Sleep Disorders and Depression
McGill 06013	High-Throughput Proteomics Pipeline
McGill 06009	Genetic marker for Molar Pregnancy
McGill 05082	Compositions of Hippurin-1 and Derivatives as Adjuvants in Chemotherapy
McGill 05077	Proportional Microvolume Capacitive Liquid Level Sensor Array
McGill 05062	Epigallocatechin Gallate Prodrugs as Anticancer Agents
McGill 05041	Prognostic test for treatment of diffuse large B-cell lymphoma
McGill 05040	Inhibitors of Aminoglycoside Acetyltransferases as Agents to Mitigate Resistance to Aminoglycoside Antibiotics
McGill 05021	Novel Microcapsules Incorporating Carbon Nanotubes for Drug Delivery
McGill 05012	Peptides to facilitate drug delivery
McGill 05003	Cell Permeable Peptide for Treatment of Allergic Airway Diseases
McGill 04086	SHOWCASE:CANCER:Novel Anti-Mitotic Peptides for the Treatment of Cancer
McGill 04062	Software for Diagnosis of Neurological Diseases
McGill 04028	Specific biomarkers for various parasitic infections
McGill 04025	Chimeric Protein as Wound Healing Agent
McGill 03050	Nucleic acid hairpins as inhibitors of HIV RNAse H
McGill 02136	Antisense Inhibitors of MBD2 Demethylase for Cancer Therapy
McGill 02024	Modulator of Lung Branching Morphogenesis and Alveolarization
McGill 01070	Peptide with TGF-ß Antagonist Properties